Fusion Antibodies – “delighted” to present annual report following “successful” admission. Really?
By Steve Moore | Thursday 16 August 2018
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Fusion Antibodies (FAB) Chairman Dr Simon Douglas is “delighted to present the first annual report for the company following our successful admission to AIM in December 2017”. Hmmm - the shares are down on the announcement at 75p, comparing to a 82p listing price. “Delighted” and “successful”, you say?...
You must be a registered member to read this story
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.